HK1092472A1 - Certain substituted spirocyclic lactams and use thereof as pharmaceuticals - Google Patents

Certain substituted spirocyclic lactams and use thereof as pharmaceuticals

Info

Publication number
HK1092472A1
HK1092472A1 HK06113107A HK06113107A HK1092472A1 HK 1092472 A1 HK1092472 A1 HK 1092472A1 HK 06113107 A HK06113107 A HK 06113107A HK 06113107 A HK06113107 A HK 06113107A HK 1092472 A1 HK1092472 A1 HK 1092472A1
Authority
HK
Hong Kong
Prior art keywords
pharmaceuticals
certain substituted
substituted spirocyclic
spirocyclic lactams
lactams
Prior art date
Application number
HK06113107A
Other languages
English (en)
Inventor
Auberson Yves
Glatthar Ralf
Salter Rhys
Simic Oliver
Tintelnot-Blomley Marina
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK1092472A1 publication Critical patent/HK1092472A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HK06113107A 2003-10-03 2006-11-29 Certain substituted spirocyclic lactams and use thereof as pharmaceuticals HK1092472A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0323204.8A GB0323204D0 (en) 2003-10-03 2003-10-03 Organic compounds
PCT/EP2004/011054 WO2005035535A1 (fr) 2003-10-03 2004-10-04 Certains lactames spirocycliques substitues et utilisation de ceux-ci comme produits pharmaceutiques

Publications (1)

Publication Number Publication Date
HK1092472A1 true HK1092472A1 (en) 2007-02-09

Family

ID=29415468

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06113107A HK1092472A1 (en) 2003-10-03 2006-11-29 Certain substituted spirocyclic lactams and use thereof as pharmaceuticals

Country Status (16)

Country Link
US (2) US20070015781A1 (fr)
EP (1) EP1670803B1 (fr)
JP (1) JP4549350B2 (fr)
CN (1) CN1863804B (fr)
AT (1) ATE388954T1 (fr)
AU (1) AU2004279553C1 (fr)
BR (1) BRPI0415015A (fr)
CA (1) CA2540249A1 (fr)
DE (1) DE602004012426T2 (fr)
ES (1) ES2300815T3 (fr)
GB (1) GB0323204D0 (fr)
HK (1) HK1092472A1 (fr)
MX (1) MXPA06003645A (fr)
PL (1) PL1670803T3 (fr)
PT (1) PT1670803E (fr)
WO (1) WO2005035535A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003293155A1 (en) * 2002-11-27 2004-06-23 Elan Pharmaceutical, Inc. Substituted ureas and carbamates
MX2007016185A (es) * 2005-06-14 2008-03-07 Schering Corp Inhibidores de aspartil proteasa heterociclicos macrociclicos.
CN101238124A (zh) 2005-07-18 2008-08-06 默克公司 用于治疗阿尔茨海默氏病的螺哌啶β-分泌酶抑制剂
US7745484B2 (en) * 2005-11-21 2010-06-29 Amgen Inc. Beta-secretase modulators and methods of use
AU2009293164B2 (en) 2008-09-18 2015-07-09 Northwestern University NMDA receptor modulators and uses thereof
GB201122113D0 (en) 2011-12-22 2012-02-01 Convergence Pharmaceuticals Novel compounds
US9708335B2 (en) * 2013-01-29 2017-07-18 Apytinyx Inc. Spiro-lactam NMDA receptor modulators and uses thereof
PE20151438A1 (es) 2013-01-29 2015-10-10 Naurex Inc Moduladores de receptores nmda de espiro-lactama y sus usos
CA2898863A1 (fr) 2013-01-29 2014-08-07 Naurex, Inc. Modulateurs spirolactames d'un recepteur nmda et leurs utilisations
BR112015018087B1 (pt) 2013-01-29 2022-09-20 Aptinyx Inc Compostos moduladores de receptor n-metil-d-aspartato (nmda) de espiro-lactama, composição farmacêutica e uso dos mesmos
WO2014120784A1 (fr) 2013-01-29 2014-08-07 Naurex, Inc. Modulateurs spirolactames d'un récepteur nmda et leurs utilisations
WO2017201283A1 (fr) 2016-05-19 2017-11-23 Aptinyx Inc. Modulateurs de récepteurs nmda de spiro-lactame et utilisations associées
WO2017201285A1 (fr) 2016-05-19 2017-11-23 Aptinyx Inc. Modulateurs spirolactames des récepteurs nmda et leurs utilisations
PE20190503A1 (es) 2016-08-01 2019-04-10 Aptinyx Inc Moduladores del receptor nmda espiro-lactam y uso de los mismos
PE20190502A1 (es) 2016-08-01 2019-04-10 Aptinyx Inc Moduladores del receptor nmda spiro-lactam y bis-spiro-lactam y uso de los mismos
PE20190500A1 (es) 2016-08-01 2019-04-10 Aptinyx Inc Moduladores del receptor nmda spiro-lactam y uso de los mismos
PE20190501A1 (es) 2016-08-01 2019-04-10 Aptinyx Inc Moduladores nmda espiro-lactam y metodos de uso de los mismos
SG11201900551WA (en) 2016-08-01 2019-02-27 Aptinyx Inc Spiro-lactam nmda receptor modulators and uses thereof
US11578072B2 (en) 2018-01-31 2023-02-14 Aptinyx Inc. Spiro-lactam NMDA receptor modulators and uses thereof
US20240174673A1 (en) * 2022-10-26 2024-05-30 Protego Biopharma, Inc. Spirocycle Containing Pyridine Compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5534520A (en) * 1990-04-10 1996-07-09 Fisher; Abraham Spiro compounds containing five-membered rings
DE69900220T2 (de) * 1998-06-12 2002-05-08 Hoffmann La Roche Diaza-spiro[3,5]nonan-Derivate
DE60027131D1 (de) * 1999-01-06 2006-05-18 Us Gov Health & Human Serv Inhibitoren für asparagin-proteasen
JP2004534017A (ja) * 2001-04-27 2004-11-11 バーテックス ファーマシューティカルズ インコーポレイテッド Baceのインヒビター
KR20070094802A (ko) * 2004-12-20 2007-09-21 시그마타우 인두스트리에 파르마슈티케 리우니테 에스.피.에이. MyD88 동종이량체화 억제제

Also Published As

Publication number Publication date
GB0323204D0 (en) 2003-11-05
MXPA06003645A (es) 2006-06-05
AU2004279553C1 (en) 2009-07-23
AU2004279553B2 (en) 2009-03-12
US20070265328A1 (en) 2007-11-15
JP4549350B2 (ja) 2010-09-22
EP1670803B1 (fr) 2008-03-12
BRPI0415015A (pt) 2006-11-07
CN1863804A (zh) 2006-11-15
AU2004279553A1 (en) 2005-04-21
ES2300815T3 (es) 2008-06-16
DE602004012426D1 (de) 2008-04-24
PL1670803T3 (pl) 2008-08-29
CN1863804B (zh) 2010-05-26
JP2007509038A (ja) 2007-04-12
PT1670803E (pt) 2008-04-23
CA2540249A1 (fr) 2005-04-21
ATE388954T1 (de) 2008-03-15
US7655686B2 (en) 2010-02-02
WO2005035535A1 (fr) 2005-04-21
DE602004012426T2 (de) 2009-03-26
US20070015781A1 (en) 2007-01-18
EP1670803A1 (fr) 2006-06-21

Similar Documents

Publication Publication Date Title
HK1092472A1 (en) Certain substituted spirocyclic lactams and use thereof as pharmaceuticals
GEP20084329B (en) 5,7-diaminopyrazolo [4,3-d] pyrimidines useful in the treatment of hypertension
MXPA05010137A (es) Derivados de tetrahidroisoquinolil acetamida para usarse como antagonistas del receptor de orexina.
MY140693A (en) [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
AU2002319814A1 (en) Substituted 1h-dihydropyrazoles, their preparation and use
NO20063355L (no) Nye trisykliske spiroderivater som modulatorer for kemokinreseptoraktivitet
MXPA02012425A (es) Compuestos nuevos.
WO2005123731A3 (fr) Composes organiques
MY142474A (en) 1h-quinazoline-2,4-diones
HK1091200A1 (en) Arylindenopyridines and arylindenopyrimidines and their use as adenosine a2a receptor antagonists
SI1730144T1 (sl) Substituirane spojine 1,4,8-triazaspiro(4.5)dekan-2-on
TW200740781A (en) Novel compounds
DE602004024213D1 (en) Aminopropanolderivate
WO2005040171A8 (fr) Derives de pyrazolo-pyrimidine et d'imidazo-pyrimidine
TW200626581A (en) Compounds, compositions containing them, preparation thereof and uses thereof
MXPA05004273A (es) Derivados de fenilalquil y piridilalquil piperazina.
WO2005000840A8 (fr) Dicetopiperazines substituees et leur utilisation comme antagonistes de l'ocytocine
MXPA05011163A (es) Derivados de 3-benzhidriliden-8-azabiciclo[3.2.1]octano con actividad de receptores opioides.
MXPA02012426A (es) Compuestos nuevos.
TW200504059A (en) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
WO2003045940A3 (fr) Composes therapeutiques
TNSN06410A1 (en) Pyrrolopyridine derivatives and their use as crth2 antagonists
BG106893A (en) NOVEL SUBSTITUTED PYRAZOLO[4,3-e]DIAZEPINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, USE AS MEDICINAL PRODUCTS AND PROCESSES FOR PREPARING THEM
MXPA05005340A (es) Nuevos derivados antagonistas del receptor de la vitronectina, sus procedimientos de preparacion, su aplicacion como medicamentos y los compuestos farmaceuticos que los contienen.
ATE345343T1 (de) Triazolo(4,5-d)pyrimidinderivate als antithrombotische verbindungen

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20111004